{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:05:42Z","timestamp":1757779542896,"version":"3.37.3"},"reference-count":15,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T00:00:00Z","timestamp":1517529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Synageva"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0191945","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T13:30:33Z","timestamp":1517578233000},"page":"e0191945","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Healthcare resource use and costs of managing children and adults with lysosomal acid lipase deficiency at a tertiary referral centre in the United Kingdom"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0162-2007","authenticated-orcid":true,"given":"Julian F.","family":"Guest","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian J.","family":"Hendriksz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusof","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"McKiernan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Mundy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Deegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,2,2]]},"reference":[{"key":"ref1","unstructured":"Grabowski GA, Du H, Charnas L. Lysosomal Acid Lipase Deficiencies: The Wolman Disease\/Cholesteryl Ester Storage Disease Spectrum. In: The Online Metabolic and Molecular Bases of Inherited Diseases. Eds: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson KM, Mitchell G. Chapter 142 doi: 10.1036\/ommbid.172<\/ext-link><\/comment>"},{"key":"ref2","unstructured":"Unit, A. L. D. Lysosomal Acid Lipase Deficiency\/ Cholesterol Ester Storage Disease. Cambridge Univ. Hosp. NHS Found. Trust 2014. Available on line at: http:\/\/www.cuh.org.uk\/addenbrookes\/services\/clinical\/lysosomal\/disorders\/lysosomal_acid_lipase_deficiency.html<\/ext-link>."},{"key":"ref3","unstructured":"Genetics Home Reference. Wolman disease. U.S. Natl. Libr. Med. (2014). Available on lone at: http:\/\/ghr.nlm.nih.gov\/condition\/wolman-disease<\/ext-link>."},{"key":"ref4","unstructured":"Orphanet. Wolman disease. Available on line at <http:\/\/www.orpha.net\/consor\/cgi-bin\/OC_Exp.php?Lng=EN&Expert=75233<\/ext-link>>."},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/ATVBAHA.107.146639","article-title":"Prevalence of cholesteryl ester storage disease","volume":"27","author":"S. Muntoni","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jhep.2013.02.014","article-title":"Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease","volume":"58","author":"DL Bernstein","year":"2013","journal-title":"J Hepatol"},{"key":"ref7","unstructured":"Department of Health. The UK Strategy for Rare Diseases. Available on line at: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/260562\/UK_Strategy_for_Rare_Diseases.pdf<\/ext-link>"},{"key":"ref8","unstructured":"Department of Health. NHS reference costs 2014 to 2015. Available at: https:\/\/www.gov.uk\/government\/publications\/nhs-reference-costs-2014-to-2015<\/ext-link>"},{"key":"ref9","unstructured":"BNF. Available at https:\/\/www.medicinescomplete.com\/mc\/bnf\/current\/<\/ext-link>"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1501365","article-title":"A Phase 3 Trial of Sebelipase Alfa in LysosomalAcid Lipase Deficiency","volume":"373","author":"BK Burton","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/MPG.0000000000000935","article-title":"Clinical Features of Lysosomal Acid Lipase Deficiency","volume":"61","author":"BK Burton","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"e009283","DOI":"10.1136\/bmjopen-2015-009283","article-title":"Health economic burden that wounds impose on the National Health Service in the UK","volume":"5","author":"JF Guest","year":"2015","journal-title":"BMJ Open"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1172-8-29","article-title":"Cost-effectiveness of enzyme replacement therapy for Fabry disease","volume":"8","author":"SM Rombach","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1750-1172-9-51","article-title":"Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease","volume":"14","author":"L van Dussen","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"e0147237","DOI":"10.1371\/journal.pone.0147237","article-title":"Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score","volume":"11","author":"EB Tapper","year":"2016","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0191945","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:45:38Z","timestamp":1540341938000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0191945"}},"subtitle":[],"editor":[{"given":"Kimon","family":"Bekelis","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,2,2]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0191945","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,2,2]]}}}